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Abstract: 
 
Background: Group B streptococcus (GBS) is the most common cause of neonatal 
sepsis in United Kingdom (UK). Early onset sepsis (EOS), but not late onset sepsis 
(LOS) can be prevented by providing intrapartum antibiotic prophylaxis (IAP). In 
spite of national guidelines since 2003, the incidence of neonatal GBS infections is 
increasing in UK.  
 
Aim: To assess the incidence of culture proven GBS infections before and after a 
change of practice on antepartum management of GBS in babies <3 months of age, 
born at Sunderland Royal Hospital between 1
st
 Jan 2008 and 31
st
 December 2017. 
 
Setting: Tertiary neonatal unit 
 
Study design: Retrospective cohort study 
 
Methods: Babies presenting with signs of sepsis from birth up to 3 months of age 
were included. Data regarding risk factors, intrapartum antibiotic prophylaxis and 
outcome of babies were collected. 
 
Results:  29 cases were identified and presented in two epochs – before and after 
changing guidelines for antepartum and intrapartum management. There was a 
statistically significant reduction in EOS rates and no difference in LOS rates. 
 
Conclusion: Prolonged rupture of membranes is a risk factor at any gestation. It is 
possible to reduce the neonatal early onset GBS disease burden by adherence to 
guidelines and timely targeted administration of IAP. 
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Introduction 
 
Group B Streptococcus (GBS), a common inhabitant of bowels and vagina is the 
commonest cause of serious neonatal infections. GBS infections in newborns are 
classified as early onset which occurs within the first 7 days of life and late onset 
which usually occurs between 8 days and 90 days of life. Early onset is vertically 
transmitted and can be prevented by intrapartum antibiotic prophylaxis (IAP). Late 
onset disease is horizontally transmitted and cannot be prevented by IAP
1
. 
 
There are two preventative strategies to reduce early onset GBS infections in newborn 
babies. One is based on routine screening of pregnant women and the second is based 
on risk factors. Both strategies involve administration of IAP to selected groups of 
pregnant women. If GBS is isolated in screening or if risk factors are present, they 
should be given IAP.  
The common risk factors for early onset infections are  
1. Previous infant with invasive GBS disease 
2. GBS bacteriuria in pregnancy 
3. Intrapartum temperature of >38
0
 C 
4. Prolonged rupture of membranes (PROM)>18 hours 
5. Preterm delivery <37 weeks gestation 
 
Centres for Disease Control (CDC) introduced guidelines on the prevention of group 
B streptococcus (GBS) infection in 1996. They are based on routine screening 
strategy in United States of America and have successfully reduced the rate of GBS 
infections from 1.7/1000 livebirths in 1993 to 0.24/1000 livebirths in 2014
1, 2
. In UK, 
we follow risk factors based strategy and national RCOG guidelines have been in 
existence since 2003 and they have been revised in 2012 and recently in 2017. In spite 
of the guidelines, the British Paediatric Surveillance Unit (BPSU) data shows the rates 
of early onset GBS infections have been increasing from 0.48/1000 livebirths (BPSU 
2002)
3
, to 0.57/1000 livebirths (BPSU 2015)
4
. The exact reason for increasing rates of 
GBS infection is not known but there is evidence about the missed opportunities to 
prevent infection by incomplete adherence of the guidelines and missing to administer 
IAP to eligible mothers.  
 
Methods 
This is a retrospective cohort study done in a tertiary neonatal unit setting. All babies 
who were born between 1
st
 January 2008 and 31
st
 December 2017 at Sunderland 
Hospital and developed GBS sepsis during this period were identified from Badgernet 
database (National neonatal database) and cross checked with microbiology 
laboratory by getting a print out of all positive blood and CSF cultures at Sunderland 
Royal Hospital (SRH). We included babies from birth up to 3 months of age to 
identify babies admitted to Paediatric wards with late onset GBS sepsis. All babies 
presented with signs of sepsis were mostly admitted to the neonatal unit and few 
babies with late onset sepsis were admitted to the Paediatric wards at SRH. Those 
who became ill within the first 7 days of age were regarded as early onset sepsis and 
those who present between 8 days and 90 days were regarded as having late onset 
sepsis. 
Based on a previous audit, guidelines on antepartum management of GBS infections 
were changed in early 2012. Therefore data has been analysed in 2 epochs - before 
(epoch 1, 2008 -2011) and after (epoch 2, 2012-2017) guideline change. In epoch 1, 
IAP was not considered if PROM was the only risk factor particularly at term 
gestation. In our analysis we identified PROM as the main risk factor in babies who 
presented with early onset GBS sepsis in epoch 1 and most of them presented within 
the first 24-48 hours of discharge from the hospital. The change in the guidelines were 
1. To give IAP if there is PROM>18 hours (irrespective of gestation) 
2. To observe babies for at least 24 hours if there is PROM in hospital 
This study was registered as a quality improvement programme with the clinical 
governance department at Sunderland Royal Hospital. 
 
Results 
A total of 29 cases of confirmed neonatal GBS sepsis were identified between 1
st
 
January 2008 and 31
st
 December 2017. There were 16 cases – 12 early onset sepsis 
(0.86/1000 livebirths) and 4 late onset sepsis (0.28/1000 livebirths) in epoch 1 (2008-
2011). In epoch 2 (2012-2017) there were 13 cases – 7 were early onset sepsis 
(0.35/1000 livebirths) and 6 late onset sepsis (0.29/1000 livebirths). We also noticed a 
higher mortality (12.5% vs 7.5%) and morbidity (31.25% vs 0%) in epoch 1 when 
compared to epoch 2. 
In epoch 1, two babies who had GBS sepsis and meningitis died (12.5% mortality) 
one at the age of 13 months and the other baby at the age of 5.5 years. Both these 
babies had significant morbidities – both had 4 limb cerebral palsy, hydrocephalus 
needing VP shunt, epilepsy, optic atrophy and deafness. A third baby with EO GBS 
sepsis developed mild dystonic cerebral palsy (18% risk of cerebral palsy). 3 babies 
had deafness (18%) and 2 babies had optic atrophy and visual problems (12.5%) and 
2 babies had cranial diabetes insipidus (12.5%). 5/16 (31.25%) had some form of 
morbidity in this cohort. 
In epoch 2, of the 7 babies with early onset sepsis, 1 died (preterm baby born at 25 
weeks) within an hour of birth (7.5% mortality) and we did not notice any morbidity 
in this cohort. 
The chi-squared test for two proportions (epoch 1 and epoch 2) was statistically 
significant There was a statistically significant reduction in EOS rates in epoch 2 (p 
value 0.04) and there were no differences in LOS rates. 
Tables – Epoch 1 and Epoch 2 
 
Discussion 
The incidence of early onset sepsis (EOS) due to GBS is increasing in UK in spite of 
national guidelines to reduce the burden of EOS. Intrapartum antibiotic prophylaxis 
(IAP) has been shown to reduce 80-90% of the early onset sepsis. There is some 
evidence the rising rate of EOS due to GBS could be due to failure to adhere to 
guidelines, lack or delay in communication of results leading to missed opportunities 
to give adequate intrapartum antibiotic prophylaxis
6
. Prolonged rupture of membranes 
(PROM>18 hours) is one of the important risk factors in predisposing babies for EOS. 
Stewardson-Krieger etal
7
 (1978) demonstrated a direct relationship between the 
duration of rupture of membrane and sepsis rate in newborns. They demonstrated the 
neonatal sepsis rate increased from 0.7/1000livebirths if the duration of ROM was 0-9 
hours to 16.8/1000 livebirths if the duration of ROM was over 19 hours, increasing to 
18.3/1000 live births if duration of ROM was more than 30 hours. Embleton etal
8
 
(2002) in their case control study have shown the odds ratio for developing EOS is 25 
times higher if there is PROM. Also there is a direct relationship between GBS load, 
risk of vertical transmission and the likelihood of serious disease in neonates. IAP 
reduces the bacterial load thereby reducing the incidence and severity of EOS. Our 
national guideline (RCOG) continues to be vague on this risk factor in term babies 
which is open to interpretation. In 2003 version of the guidelines, it recommended to 
‘consider’ IAP if there was PROM and in the subsequent revisions, the 
recommendation for IAP is not clear
9
. Centres for Disease Control (CDC), Canadian, 
Australian and New Zealand guidelines clearly recommend giving  IAP if there is 
prolonged rupture of membranes for >18 hours and if GBS status is not known at any 
gestation. A recent metaanalysis of randomized trials on antibiotic prophylaxis for 
term or near term premature rupture of membranes has shown not only a reduction in 
neonatal sepsis but also a significant reduction in maternal chorioamnionitis and 
endometritis when the latency was longer than 12 hours (Berghella etal 2015)
10
. The 
recent revision of RCOG guidelines identifies prolonged rupture of membranes as risk 
factor and recommends induction of labour for term prelabour rupture of membranes 
but is evasive in clearly recommending IAP if the latency is more than 18 hours. It 
clearly recommends giving IAP for preterm PROM but it is not clear for PROM at 
term. For any national clinical guidelines to be effective, it needs to be correctly 
interpreted and implemented. This will happen only when the guidelines are clear and 
consistent. 
 
In our cohort of babies in epoch 1, we could have given IAP for 5 mothers for 
PROM and therefore missed opportunity to prevent GBS infections. Probably the 
increased mortality and morbidity of babies in epoch 1 could be due to increased 
bacterial load which is however difficult to prove retrospectively. We identified 
PROM as a risk factor in our babies and we decided to give IAP to mothers if there is 
PROM of >18 hours in epoch 2. We believe that has contributed in reducing the early 
onset GBS neonatal sepsis in epoch 2.  
 Conclusions 
Though IAP reduces EOS due to GBS there are drawbacks as well. As it is given at 
the time of labour it will not be able to prevent stillbirths, preterm births and 
miscarriage due to GBS. Also there are concerns related to antibiotic exposure during 
the neonatal period influencing neonatal intestinal microbiome and an association 
between early antibiotic exposure in newborns and increased rate of allergies in 
babies including cow’s milk protein allergy.11, 12, 13 The ideal way for preventing 
neonatal GBS is through maternal immunisation with GBS vaccines which will 
reduce neonatal sepsis, miscarriage, preterm births and still births. Until we have a 
good GBS vaccine, IAP remains the best effective strategy in preventing GBS 
infections in neonates. There is some evidence that though IAP does not prevent late 
onset sepsis, it delays the onset and reduces the severity of late infection
14
. The major 
limitation of our study is our small sample size. It will be interesting to do a subgroup 
analysis on recent BPSU data on GBS sepsis which included 856 babies with GBS 
sepsis to look for PROM as an isolated risk factor at term gestation. We request our 
national guidelines group on prevention of neonatal GBS sepsis to consider 
recommending IAP for PROM at term gestation as well. It is possible to reduce GBS 
disease burden in UK if the guidelines are correctly interpreted and implemented by 
timely administration of IAP to eligible mothers.  
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Epoch 1 (2008-2011) 
Year Live 
births 
EOS 
(Number) 
EOS/1000 
live births 
LOS 
(Number) 
LOS/1000 
live births 
2008 3546 4 1.12 3 0.84 
2009 3328 1 0.3 0 0 
2010 3436 0 0 1 0.3 
2011 3574 7 2 0 0 
Cumulative 13884
* 
12 0.86
* 
4 0.28 
 
Epoch 2 (2012-2017) 
Year Live births EOS 
(Number) 
EOS per 
1000 live 
births 
LOS 
(Number) 
LOS per 
1000 live 
births 
2012 3384 1 0.3 1 0.29 
2013 3295 1 0.3 1 0.3 
2014 3436 1 0.3 2 0.6 
2015 3158 3 0.9 1 0.3 
2016 3334 1 0.3 0 0 
2017 3228 0 0 1 0.3 
Cumulative 19835
* 
7 0.35
* 
6 0.29 
 
*The chi-squared test for two proportions (epoch 1 and epoch 2) was statistically 
significant with X = 3.8, df = 1, p-value = 0.04, the 95% CI [4.62e-05, 1.0]
5
; since we 
calculate EOS rate per thousand live births, the two proportions are 0.86 and 0.35. 
The exact 1-sided significance value was chosen based on our confidence of the new 
guidelines on prevention of GBS infection methods in Epoch2. 
 
